Tezosentan in Patients With Pulmonary Arterial Hypertension

Mise à jour : Il y a 4 ans
Référence : NCT01094067

Femme et Homme

Extrait

Multicenter, double-blind, randomized, placebo-controlled, cross-over study to demonstrate that a single infusion of tezosentan has minimal effect on blood pressure in patients with pulmonary arterial hypertension, treated with endothelin receptor antagonists, phosphodiesterase-5 inhibitors or a combination of both.


Critère d'inclusion

  • pulmonary arterial hypertension

Liens